IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-36183-y.html
   My bibliography  Save this article

Regions of hepatitis C virus E2 required for membrane association

Author

Listed:
  • Ashish Kumar

    (National Institutes of Health)

  • Tiana C. Rohe

    (National Institutes of Health)

  • Elizabeth J. Elrod

    (Emory University School of Medicine)

  • Abdul G. Khan

    (The State University of New Jersey)

  • Altaira D. Dearborn

    (National Institutes of Health)

  • Ryan Kissinger

    (National Institutes of Health)

  • Arash Grakoui

    (Emory University School of Medicine)

  • Joseph Marcotrigiano

    (National Institutes of Health)

Abstract

Hepatitis C virus (HCV) uses a hybrid entry mechanism. Current structural data suggest that upon exposure to low pH and Cluster of Differentiation 81 (CD81), the amino terminus of envelope glycoprotein E2 becomes ordered and releases an internal loop with two invariant aromatic residues into the host membrane. Here, we present the structure of an amino-terminally truncated E2 with the membrane binding loop in a bent conformation and the aromatic side chains sequestered. Comparison with three previously reported E2 structures with the same Fab indicates that this internal loop is flexible, and that local context influences the exposure of hydrophobic residues. Biochemical assays show that the amino-terminally truncated E2 lacks the baseline membrane-binding capacity of the E2 ectodomain. Thus, the amino terminal region is a critical determinant for both CD81 and membrane interaction. These results provide new insights into the HCV entry mechanism.

Suggested Citation

  • Ashish Kumar & Tiana C. Rohe & Elizabeth J. Elrod & Abdul G. Khan & Altaira D. Dearborn & Ryan Kissinger & Arash Grakoui & Joseph Marcotrigiano, 2023. "Regions of hepatitis C virus E2 required for membrane association," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36183-y
    DOI: 10.1038/s41467-023-36183-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-36183-y
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-36183-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Benjamin M. Janus & Nydia van Dyk & Xuelian Zhao & Katie A. Howell & Cinque Soto & M. Javad Aman & Yuxing Li & Thomas R. Fuerst & Gilad Ofek, 2018. "Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop," Nature Communications, Nature, vol. 9(1), pages 1-12, December.
    2. Ashish Kumar & Reafa A. Hossain & Samantha A. Yost & Wei Bu & Yuanyuan Wang & Altaira D. Dearborn & Arash Grakoui & Jeffrey I. Cohen & Joseph Marcotrigiano, 2021. "Structural insights into hepatitis C virus receptor binding and entry," Nature, Nature, vol. 598(7881), pages 521-525, October.
    3. Abdul Ghafoor Khan & Jillian Whidby & Matthew T. Miller & Hannah Scarborough & Alexandra V. Zatorski & Alicja Cygan & Aryn A. Price & Samantha A. Yost & Caitlin D. Bohannon & Joshy Jacob & Arash Grako, 2014. "Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2," Nature, Nature, vol. 509(7500), pages 381-384, May.
    4. Matthew J. Evans & Thomas von Hahn & Donna M. Tscherne & Andrew J. Syder & Maryline Panis & Benno Wölk & Theodora Hatziioannou & Jane A. McKeating & Paul D. Bieniasz & Charles M. Rice, 2007. "Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry," Nature, Nature, vol. 446(7137), pages 801-805, April.
    5. Alexander Ploss & Matthew J. Evans & Valeriya A. Gaysinskaya & Maryline Panis & Hana You & Ype P. de Jong & Charles M. Rice, 2009. "Human occludin is a hepatitis C virus entry factor required for infection of mouse cells," Nature, Nature, vol. 457(7231), pages 882-886, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pranesh Padmanabhan & Narendra M Dixit, 2011. "Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry," PLOS Computational Biology, Public Library of Science, vol. 7(12), pages 1-11, December.
    2. Pranesh Padmanabhan & Narendra M Dixit, 2012. "Viral Kinetics Suggests a Reconciliation of the Disparate Observations of the Modulation of Claudin-1 Expression on Cells Exposed to Hepatitis C Virus," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-7, April.
    3. Mphatso Kalemera & Dilyana Mincheva & Joe Grove & Christopher J R Illingworth, 2019. "Building a mechanistic mathematical model of hepatitis C virus entry," PLOS Computational Biology, Public Library of Science, vol. 15(3), pages 1-26, March.
    4. Joan Capella-Pujol & Marlon Gast & Laura Radić & Ian Zon & Ana Chumbe & Sylvie Koekkoek & Wouter Olijhoek & Janke Schinkel & Marit J. Gils & Rogier W. Sanders & Kwinten Sliepen, 2023. "Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    5. Matthew C. Metcalf & Benjamin M. Janus & Rui Yin & Ruixue Wang & Johnathan D. Guest & Edwin Pozharski & Mansun Law & Roy A. Mariuzza & Eric A. Toth & Brian G. Pierce & Thomas R. Fuerst & Gilad Ofek, 2023. "Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    6. Kwinten Sliepen & Laura Radić & Joan Capella-Pujol & Yasunori Watanabe & Ian Zon & Ana Chumbe & Wen-Hsin Lee & Marlon Gast & Jelle Koopsen & Sylvie Koekkoek & Iván Moral-Sánchez & Philip J. M. Brouwer, 2022. "Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36183-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.